EMCN and neoplasm: Although we identified several sequence variations in three tumour-derived cDNAs (NUCB2, endomucin-2 and CGI-96), analysis of these sequences in tumour and normal tissue specimens indicates that these variations represent allelic polymorphisms and are not likely to be associated with the immunogenicity of these proteins.